Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)

NCT05049044 is registered in ClinicalTrials.gov with Groupe Francais De Pneumo-Cancerologie as lead sponsor.

NCT NCT05049044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05049044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)
Lead sponsor
Groupe Francais De Pneumo-Cancerologie
Phase
Observational
Overall status
Active, not recruiting
Start date
December 18, 2020
Completion date
June 30, 2027
Enrollment
413 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer